Packaged Foods and Meats

CCGB

CCGB released FY2026 Q1 earnings on April 24 After-Market (BJT), actual revenue CNY 1.629 B, actual EPS CNY 0.2002

CCGB to Release FY2026 Q1 Earnings on April 25 After-Market (BJT)

CCGB to Release FY2025 Annual Earnings on March 31 After-Market (BJT), Forecast Revenue CNY 7.038 B, EPS CNY 0.8006

CCGB released FY2025 earnings on February 27 After-Market (BJT), actual revenue CNY 6.559 B (forecast CNY 7.038 B), actual EPS CNY 0.7636 (forecast CNY 0.8006)

CCGB released FY2025 Q4 earnings on February 27 After-Market (BJT), actual revenue CNY 1.512 B, actual EPS CNY 0.1339 (forecast EPS CNY 0.2258)

CCGB released FY2025 Q3 earnings on October 24 During-Market (BJT), actual revenue CNY 1.39 B, actual EPS CNY 0.1891 (forecast EPS CNY 0.1864)

CCGB released FY2025 9 Months Earnings on October 24 During-Market (BJT), Actual Revenue CNY 5.047 B, Actual EPS CNY 0.6293

CCGB to Release FY2025 Q3 Earnings on October 25 During-Market (BJT), Forecast EPS CNY 0.1864

CCGB released FY2025 Q2 earnings on August 25 After-Market (BJT), actual revenue CNY 1.941 B, actual EPS CNY 0.2135 (forecast EPS CNY 0.239)

CCGB released FY2025 Semi-Annual earnings on August 25 After-Market (BJT), actual revenue CNY 3.658 B, actual EPS CNY 0.44

CCGB FY2025 Semi-Annual Earnings Release on August 26, 2025 (BJT)

Chongguang Biotech Responds to Trend of Natural Pigments Replacing Synthetic Ones

Chongguang Biotech Sees Significant Q2 2025 Net Profit Growth

Chongguang Biotech's Isogreenic Acid Sodium Approved as New Feed Additive

Chenguang Biotech's ESG Rating Dropped from B to CCC

Southwest Securities Gives Buy Rating to ChenGuang Biotech

Champion Biotech Delays Some R&D Projects

Southwest Securities Gives Buy Rating to ChenGuang Bio

Explanation of Chenguang Biotech's Sweetener Products

Chongguang Bio's Stevia Sales Increased by About 40% in Q1

300138

According to the Zhitong Finance APP, CCGB released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 5.047 billion yuan, a year-on-year decrease of 3.41%. The net profit attributable to shareholders of the listed company was 304 million yuan, a year-on-year increase of 385.30%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 256 million yuan, a year-on-year increase of 1659.00%. The basic earnings per share were 0.63 yuan

Zhitong

CCGB released its performance for the first three quarters, with a net profit attributable to the parent company of 304 million yuan, an increase of 385.3%

CCGB expects the net profit attributable to shareholders for the first three quarters of 2025 to be between 278 million yuan and 314 million yuan, a year-on-year increase of 344.05% to 401.55%. The net profit after deducting non-recurring gains and losses is expected to be between 218 million yuan and 254 million yuan, a year-on-year increase of 1398.00% to 1645.38%. The main revenue and gross profit growth from plant extraction products, along with the cottonseed business turning profitable, have significantly boosted overall performance

CCGB issued a preliminary increase, expecting the net profit attributable to the parent company for the first three quarters to be between 278 million yuan and 314 million yuan, an increase of 344.05% to 401.55%

Shanxi Securities released a research report stating that as the U.S. HHS and FDA plan to gradually phase out petroleum-based synthetic food colorings, domestic natural pigment companies will benefit from a surge in demand, recommending attention to CCGB. The company is actively promoting the market application of products such as paprika red, lycopene, and lutein, and is expected to benefit from this. The U.S. market's natural pigments will fully replace synthetic pigments, and the FDA will accelerate the review of natural pigments and collaborate with NIH to study the impact of food additives on children's health

Shanxi Securities: Domestic natural pigment companies may benefit from demand explosion, recommend paying attention to CCGB

CCGB released its semi-annual report for 2025, with operating revenue of 3.658 billion yuan, a year-on-year increase of 4.77%; net profit attributable to the parent company of 215 million yuan, a year-on-year increase of 115.33%; net profit excluding non-recurring gains and losses of 184 million yuan, a year-on-year increase of 130.48%; basic earnings per share of 0.44 yuan

CCGB released its performance for the first half of the year, with a net profit attributable to the parent company of 215 million yuan, a year-on-year increase of 115.33%

000990

300194

Rhein Biotech hit the daily limit, Fuan Pharmaceutical and CCGB rose over 5%, while Yongji Co., Ltd., Dezhan Health, Chengzhi, and Kang En Bei also followed suit

Chengzhi

Fuan Pharmaceutical

Industrial hemp concept stocks opened strong, with Rhine Biotech hitting the daily limit

CCGB expects its net profit attributable to shareholders in the first half of 2025 to be between 202 million yuan and 232 million yuan, a year-on-year increase of 102.33% to 132.38%. The net profit after deducting non-recurring gains and losses is expected to be between 174 million yuan and 204 million yuan, a year-on-year increase of 117.40% to 154.88%. This is mainly benefited from the recovery of the cottonseed business and the growth of gross profit in the plant extraction business

CCGB expects a profit increase, with the estimated net profit attributable to the parent company for the first half of the year to be between 202 million and 232 million yuan, a year-on-year increase of 102.33% to 132.38%

605016

605589

002597

Since the beginning of this year, the overall performance of sugar substitute concept stocks has been strong. According to statistics, as of the close on July 2, the average increase of concept stocks this year is 20.51%, significantly outperforming the Shanghai Composite Index during the same period. Bailong Chuangyuan, Baolingbao, Ruizhi Pharmaceutical, CCGB, and JHSY have all seen cumulative increases of over 40%. In terms of research report ratings, according to Data Treasure statistics, there are 8 concept stocks that have received "positive" ratings from more than 5 institutions, including Sun Paper, SQ Group, Meihua Biological, JHSY, CCGB, and Bailong Chuangyuan

Bailong Chuangyuan

SQ Group

JHSY

ChemPartner

MEIHUABIO;Mei Hua Group

SSE Index

SUN PAPER

Jinhe Biotechnology

The overall performance of sugar substitute concept stocks is strong. A list of sugar substitute concept stocks that institutions are paying attention to

CCGB announced that some fundraising projects have been postponed. The company's board of directors and supervisory board approved the postponement proposal, which involves natural plant comprehensive extraction, nutritional medicinal comprehensive extraction, and land development projects in Zambia. The new completion dates are June 30, 2027, April 30, 2027, and December 31, 2026, respectively. The reasons for the postponement include changes in the global economic environment, slow market expansion, and optimization of production processes. The company promises to use the raised funds legally and effectively, and this postponement will not have a significant adverse impact on normal operations

CCGB: Some fundraising projects have been postponed

CCGB disclosed in the investor relations activity record that, from a strategic perspective, the company had planned to list its cottonseed segment on the Beijing Stock Exchange, but later withdrew the application materials due to changes in market conditions and other factors. In the future, if suitable opportunities arise, the company will continue to promote the development of its cottonseed business. Currently, the company's cottonseed business capacity is among the industry leaders, and there are no plans to increase capacity at this time

CCGB: The capacity scale of the cottonseed business is among the industry leaders, and there are currently no plans for production increase

According to the Zhitong Finance APP, CCGB released its first-quarter report for 2025, with operating revenue of 1.716 billion yuan, a year-on-year decrease of 0.92%. The net profit attributable to shareholders of the listed company was 109 million yuan, a year-on-year increase of 183.69%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 95.9237 million yuan, a year-on-year increase of 97.83%. The basic earnings per share were 0.2266 yuan

CCGB released its first-quarter performance, with a net profit attributable to the parent company of 109 million yuan, an increase of 183.69%

CCGB(300138.SZ)